208 related articles for article (PubMed ID: 28470092)
21. The role of
Sun J; Fei F; Zhang M; Li Y; Zhang X; Zhu S; Zhang S
BMC Cancer; 2019 May; 19(1):450. PubMed ID: 31088406
[TBL] [Abstract][Full Text] [Related]
22. Epi proColon
Shirley M
Mol Diagn Ther; 2020 Aug; 24(4):497-503. PubMed ID: 32557236
[TBL] [Abstract][Full Text] [Related]
23.
Laven-Law G; Kichenadasse G; Young GP; Symonds EL; Winter JM
Biomarkers; 2024 Jun; 29(4):194-204. PubMed ID: 38644767
[TBL] [Abstract][Full Text] [Related]
24. Detection of Methylated SEPT9 in Korean Colorectal Cancer Patients: Comparison with Previous Studies.
Kim H; Lee JK; Hong YJ; Moon SM; Shin US; Kwon H; Shin K; Chang YH
Clin Lab; 2018 Sep; 64(9):1573-1579. PubMed ID: 30273999
[TBL] [Abstract][Full Text] [Related]
25. Potential of quantitative SEPT9 and SHOX2 methylation in plasmatic circulating cell-free DNA as auxiliary staging parameter in colorectal cancer: a prospective observational cohort study.
Bergheim J; Semaan A; Gevensleben H; Groening S; Knoblich A; Dietrich J; Weber J; Kalff JC; Bootz F; Kristiansen G; Dietrich D
Br J Cancer; 2018 May; 118(9):1217-1228. PubMed ID: 29610456
[TBL] [Abstract][Full Text] [Related]
26. Simultaneous Analysis of SEPT9 Promoter Methylation Status, Micronuclei Frequency, and Folate-Related Gene Polymorphisms: The Potential for a Novel Blood-Based Colorectal Cancer Biomarker.
Ravegnini G; Zolezzi Moraga JM; Maffei F; Musti M; Zenesini C; Simeon V; Sammarini G; Festi D; Hrelia P; Angelini S
Int J Mol Sci; 2015 Dec; 16(12):28486-97. PubMed ID: 26633373
[TBL] [Abstract][Full Text] [Related]
27. Performance of a Novel Blood-Based Early Colorectal Cancer Screening Assay in Remaining Serum after the Blood Biochemical Test.
Chen Y; Wang Z; Zhao G; Sun C; Ma Y; Zhang L; Zheng M; Li H
Dis Markers; 2019; 2019():5232780. PubMed ID: 31089394
[TBL] [Abstract][Full Text] [Related]
28. High methylation of the SEPT9 gene in Chinese colorectal cancer patients.
Su XL; Wang YF; Li SJ; Zhang F; Cui HW
Genet Mol Res; 2014 Jan; 13(2):2513-20. PubMed ID: 24535900
[TBL] [Abstract][Full Text] [Related]
29. Performance of epigenetic markers SEPT9 and ALX4 in plasma for detection of colorectal precancerous lesions.
Tänzer M; Balluff B; Distler J; Hale K; Leodolter A; Röcken C; Molnar B; Schmid R; Lofton-Day C; Schuster T; Ebert MP
PLoS One; 2010 Feb; 5(2):e9061. PubMed ID: 20140221
[TBL] [Abstract][Full Text] [Related]
30. The Pathological Features of Colorectal Cancer Determine the Detection Performance on Blood ctDNA.
He N; Song L; Kang Q; Jin P; Cai G; Zhou J; Zhou G; Sheng J; Cai S; Wang J; Han X; Nie Y; Wu K
Technol Cancer Res Treat; 2018 Jan; 17():1533033818791794. PubMed ID: 30223720
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic Value and Clinical Significance of Methylated SEPT9 for Colorectal Cancer: A Meta-Analysis.
Hu J; Hu B; Gui YC; Tan ZB; Xu JW
Med Sci Monit; 2019 Aug; 25():5813-5822. PubMed ID: 31378778
[TBL] [Abstract][Full Text] [Related]
32. Methylation profile of colon cancer genes in colorectal precursor lesions and tumor tissue: perspectives for screening.
Sobanski T; Arantes LMRB; Dos Santos W; Matsushita M; de Oliveira MA; Costa M; de Carvalho AC; Berardinelli GN; Syrjänen K; Reis RM; Guimarães DP
Scand J Gastroenterol; 2021 Aug; 56(8):920-928. PubMed ID: 34218733
[TBL] [Abstract][Full Text] [Related]
33. Epi proColon
Lamb YN; Dhillon S
Mol Diagn Ther; 2017 Apr; 21(2):225-232. PubMed ID: 28155091
[TBL] [Abstract][Full Text] [Related]
34. From discovery to the clinic: the novel DNA methylation biomarker (m)SEPT9 for the detection of colorectal cancer in blood.
Payne SR
Epigenomics; 2010 Aug; 2(4):575-85. PubMed ID: 22121975
[TBL] [Abstract][Full Text] [Related]
35. SFRP2 methylation in fecal DNA--a marker for colorectal polyps.
Oberwalder M; Zitt M; Wöntner C; Fiegl H; Goebel G; Zitt M; Köhle O; Mühlmann G; Ofner D; Margreiter R; Müller HM
Int J Colorectal Dis; 2008 Jan; 23(1):15-9. PubMed ID: 17639423
[TBL] [Abstract][Full Text] [Related]
36. A First Step to a Biomarker of Curative Surgery in Colorectal Cancer by Liquid Biopsy of Methylated Septin 9 Gene.
Leon Arellano M; García-Arranz M; Ruiz R; Olivera R; Magallares S; Olmedillas-Lopez S; Valdes-Sanchez T; Guadalajara H; García-Olmo D
Dis Markers; 2020; 2020():9761406. PubMed ID: 32566042
[TBL] [Abstract][Full Text] [Related]
37. Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas.
Zhang X; Song YF; Lu HN; Wang DP; Zhang XS; Huang SL; Sun BL; Huang ZG
World J Gastroenterol; 2015 Mar; 21(9):2629-37. PubMed ID: 25759530
[TBL] [Abstract][Full Text] [Related]
38. Analysis of
Park YS; Kim DS; Cho SW; Park JW; Jeon SJ; Moon TJ; Kim SH; Son BK; Oh TJ; An S; Kim JH; Chae JD
Gut Liver; 2018 Sep; 12(5):508-515. PubMed ID: 29730903
[TBL] [Abstract][Full Text] [Related]
39. Algorithm Optimization in Methylation Detection with Multiple RT-qPCR.
Song L; Li Y; Jia J; Zhou G; Wang J; Kang Q; Jin P; Sheng J; Cai G; Cai S; Han X
PLoS One; 2016; 11(11):e0163333. PubMed ID: 27898666
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic value of aberrant gene methylation in stool samples for colorectal cancer or adenomas: a meta-analysis.
Yuan Y; Qu B; Yan J; Wang H; Yin L; Han Q
Panminerva Med; 2015 Jun; 57(2):55-64. PubMed ID: 25256821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]